BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12746304)

  • 1. Estrogen-like activity of metals in MCF-7 breast cancer cells.
    Martin MB; Reiter R; Pham T; Avellanet YR; Camara J; Lahm M; Pentecost E; Pratap K; Gilmore BA; Divekar S; Dagata RS; Bull JL; Stoica A
    Endocrinology; 2003 Jun; 144(6):2425-36. PubMed ID: 12746304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
    Stoica A; Pentecost E; Martin MB
    Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of estrogen receptor-alpha by the heavy metal cadmium.
    Stoica A; Katzenellenbogen BS; Martin MB
    Mol Endocrinol; 2000 Apr; 14(4):545-53. PubMed ID: 10770491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
    Stoica A; Pentecost E; Martin MB
    J Cell Biochem; 2000 Aug; 79(2):282-92. PubMed ID: 10967555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tobacco smoke condensate on estrogen receptor-alpha gene expression and activity.
    Martin MB; Reiter R; Johnson M; Shah MS; Iann MC; Singh B; Richards JK; Wang A; Stoica A
    Endocrinology; 2007 Oct; 148(10):4676-86. PubMed ID: 17640996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
    Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
    J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells.
    Garcia-Morales P; Saceda M; Kenney N; Kim N; Salomon DS; Gottardis MM; Solomon HB; Sholler PF; Jordan VC; Martin MB
    J Biol Chem; 1994 Jun; 269(24):16896-901. PubMed ID: 8207012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells.
    Cassoni P; Catalano MG; Sapino A; Marrocco T; Fazzari A; Bussolati G; Fortunati N
    Int J Oncol; 2002 Aug; 21(2):375-8. PubMed ID: 12118334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
    Brünner N; Boulay V; Fojo A; Freter CE; Lippman ME; Clarke R
    Cancer Res; 1993 Jan; 53(2):283-90. PubMed ID: 8380254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells.
    Cavaillès V; Gompel A; Portois MC; Thénot S; Mabon N; Vignon F
    J Mol Endocrinol; 2002 Jun; 28(3):165-75. PubMed ID: 12063183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells.
    Stoner M; Saville B; Wormke M; Dean D; Burghardt R; Safe S
    Mol Endocrinol; 2002 Oct; 16(10):2231-42. PubMed ID: 12351689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.